Proscia logo

Proscia

Challenger

Proscia provides a digital pathology platform (Concentriq) that digitizes glass slide workflows and applies AI to accelerate and improve cancer diagnosis; raised $37M including a $25M Series B; FDA-cleared AI applications;

Best for: Digital & Computational Pathology Platform for Cancer Diagnosis
HealthcareDigital & Computational Pathology Platform for Cancer DiagnosisWebsiteUpdated May 2026

Company Overview

About Proscia

Proscia is a Philadelphia-based health technology company founded in 2014 that has developed a digital and computational pathology platform — called Concentriq — designed to transform how pathologists diagnose cancer and how pharmaceutical companies conduct drug discovery research. Pathology has historically been one of the last medical specialties to transition from analog to digital workflows: the standard of care still involves pathologists examining glass microscope slides by hand under optical microscopes. Proscia's Concentriq platform digitizes these glass slides using whole-slide imaging scanners, stores the resulting high-resolution digital images in a cloud-based repository, and provides pathologists with an AI-augmented viewer that can highlight diagnostic features, flag regions of interest, and assist with quantitative analysis that would be time-consuming or impossible to perform manually.

Business Model & Competitive Advantage

Proscia has raised $37M in total funding including a $25M Series B from investors including Leeds Illuminate, Northpond Ventures, and others. The company's AI applications, which are FDA-cleared for clinical use, assist pathologists with tasks such as detecting cancer cells in prostate and breast biopsy slides, quantifying biomarker expression (such as HER2 and PD-L1 staining), and flagging normal-appearing slides that may contain subtle abnormalities. Concentriq also serves the pharmaceutical and biotech industry for digital pathology in drug discovery and clinical trials, where the ability to analyze millions of tissue images computationally is a significant research accelerant. Major academic medical centers and leading pharmaceutical companies including Merck and AstraZeneca have partnered with Proscia.

Competitive Landscape 2025–2026

Proscia competes in the digital pathology market alongside Leica Biosystems (Aperio), Philips Digital Pathology, and emerging computational pathology companies like PathAI, Paige, and Nucleai. Its differentiation lies in the combination of enterprise workflow management (Concentriq as a lab information management layer), AI applications, and a platform architecture that supports both clinical diagnostics and pharma research — making it a comprehensive digital pathology solution rather than a standalone AI algorithm vendor. The digital pathology market is growing rapidly driven by FDA regulatory guidance supporting digital primary diagnosis and the increasing adoption of AI-assisted review in cancer centers.

Founded
2014
Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Proscia is an established challenger with significant market presence and competitive offerings in Healthcare.

Frequently Asked Questions

Similar Brands

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

PointClickCare logo

PointClickCare

Senior Care Tech
B2bB2cEnterpriseHealthtechPlatformSaasUnicorn

PointClickCare is North America's leading cloud-based software platform for the long-term and post-acute care (LTPAC) market, headquartered in Mississauga, Ontario, Canada. Founded in 1999, the compan

CoverMyMeds logo

CoverMyMeds

Healthcare Revenue Cycle & Health IT
HealthtechB2bPlatformEnterpriseServicesTechnologyAutomationAnalytics

CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline t

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Compare Proscia with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Proscia

Claim This Profile

Are you from Proscia? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Proscia Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Proscia vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →